
Pattern Bioscience has surpassed 1,000 samples in our multi-center U.S. clinical trial of a rapid, direct-from-specimen pneumonia ID/AST panel, marking the halfway point of the study designed to support our FDA 510(k) submission.
Learn more: pattern.bio/pattern-biosci…
English
























